BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 36126725)

  • 1. Functional roles of lncRNA-TUG1 in hepatocellular carcinoma.
    Farzaneh M; Ghasemian M; Ghaedrahmati F; Poodineh J; Najafi S; Masoodi T; Kurniawan D; Uddin S; Azizidoost S
    Life Sci; 2022 Nov; 308():120974. PubMed ID: 36126725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a long non-coding RNA regulator of liver carcinoma cell survival.
    Rybakova Y; Gonzalez JT; Bogorad R; Chauhan VP; Dong YL; Whittaker CA; Zatsepin T; Koteliansky V; Anderson DG
    Cell Death Dis; 2021 Feb; 12(2):178. PubMed ID: 33589614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of long non-coding RNA in hepatocellular carcinoma.
    Liang W; Zhao Y; Meng Q; Jiang W; Deng S; Xue J
    Aging (Albany NY); 2024 Feb; 16(4):4052-4073. PubMed ID: 38334963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).
    Huang Q; Liang Z; Huang Q; Li X; Xia J; Huang L; Huang LB; Ou C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs.
    Chen H; Han Z; Su J; Song X; Ma Q; Lin Y; Ran Z; Li X; Mou R; Wang Y; Li D
    Front Immunol; 2024; 15():1424954. PubMed ID: 38846953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].
    Yu Z; Chen DM; Huang JL
    Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):180-185. PubMed ID: 38514271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies.
    Rashwan HH; Taher AM; Hassan HA; Awaji AA; Kiriacos CJ; Assal RA; Youness RA
    Pathol Res Pract; 2024 Apr; 256():155223. PubMed ID: 38452587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA taurine upregulated gene 1 in liver disease.
    Fan Z; Pan H; Qu N; Wang X; Cao L; Chen L; Liu M
    Clin Chim Acta; 2024 May; 560():119752. PubMed ID: 38821337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of long non-coding RNAs in hepatocellular carcinoma: an update.
    Peng L; Yuan XQ; Zhang CY; Peng JY; Zhang YQ; Pan X; Li GC
    J Cancer; 2018; 9(14):2549-2558. PubMed ID: 30026854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TUG1 and its Molecular Mechanisms in Human Cancer.
    Wu S; Wu K; Yang Y; Ou Z; Lei X; Yang X
    Curr Mol Med; 2024 May; ():. PubMed ID: 38779739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.
    Chen S; Liu P; Zhao L; Han P; Liu J; Yang H; Li J
    Front Immunol; 2022; 13():954653. PubMed ID: 36189204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy.
    Zhang M; Zhang Y; Ding Y; Huang J; Yao J; Xie Z; Lv Y; Zuo J
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA PAARH impacts liver cancer cell proliferation by engaging miR‑6512‑3p to target LASP1.
    Wei Q; Liu G; Huang Z; Nian J; Huang L; Huang Y; Huang Z; Pu J
    Oncol Lett; 2024 Jul; 28(1):306. PubMed ID: 38774456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Important role and underlying mechanism of non‑SMC condensin I complex subunit G in tumours (Review).
    Li R; Wang D; Yang H; Pu L; Li X; Yang F; Zhu R
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38639175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conceptual breakthroughs of the long noncoding RNA functional system and its endogenous regulatory role in the cancerous regime.
    Wang A
    Explor Target Antitumor Ther; 2024; 5(1):170-186. PubMed ID: 38464381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA
    Huang Y; Li D; Lu L; Song D; Li P
    Transl Cancer Res; 2024 Jan; 13(1):423-436. PubMed ID: 38410227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of competing endogenous RNA network in the development of hepatocellular carcinoma: potential therapeutic targets.
    Tang Z; Li X; Zheng Y; Liu J; Liu C; Li X
    Front Cell Dev Biol; 2024; 12():1341999. PubMed ID: 38357004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.
    Fattahi M; Rezaee D; Fakhari F; Najafi S; Aghaei-Zarch SM; Beyranvand P; Rashidi MA; Bagheri-Mohammadi S; Zamani-Rarani F; Bakhtiari M; Bakhtiari A; Falahi S; Kenarkoohi A; Majidpoor J; Nguyen PU
    Cell Death Discov; 2023 Nov; 9(1):423. PubMed ID: 38001121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Mechanisms of Long Non-coding RNA-XIST in Ischemic Stroke: Insights into Functional Roles and Therapeutic Potential.
    Farzaneh M; Anbiyaee O; Azizidoost S; Nasrolahi A; Ghaedrahmati F; Kempisty B; Mozdziak P; Khoshnam SE; Najafi S
    Mol Neurobiol; 2024 May; 61(5):2745-2753. PubMed ID: 37932544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma.
    Ghasemian M; Babaahmadi-Rezaei H; Khedri A; Selvaraj C
    J Cell Mol Med; 2023 Dec; 27(24):3966-3973. PubMed ID: 37772815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.